Alignment Health Plan Recognized as One of Two Medicare Advantage Prescription Drug Plans in the U.S. for Excellence in Pharmacy Quality
Alignment Healthcare (NASDAQ: ALHC) has received the 2025 PQA Laura Cranston Excellence in Quality Award for its Medicare Advantage prescription drug (MAPD) plan. The company was one of only two MAPD plans out of 633 eligible contracts to achieve this recognition, representing the top 1.3%. The award requires a minimum 4.5-star Part D summary rating and a perfect 5-star rating on all five PQA medication measures used in CMS's star ratings program.
The recognition marks Alignment's sixth time receiving this honor, having previously won the PQA Excellence in Quality Award from 2018 to 2022. The company achieved perfect ratings in medication adherence for diabetes, hypertension, and cholesterol medications, as well as in medication therapy management program completion and statin use in persons with diabetes.
Alignment Healthcare (NASDAQ: ALHC) ha ricevuto il Premio di Eccellenza nella Qualità Laura Cranston 2025 da PQA per il suo piano Medicare Advantage con copertura farmaceutica (MAPD). L'azienda è stata una delle sole due su 633 contratti idonei a ottenere questo riconoscimento, rappresentando il top 1,3%. Il premio richiede una valutazione minima di 4,5 stelle nella sintesi della Parte D e un punteggio perfetto di 5 stelle in tutte e cinque le misure di farmaci PQA utilizzate nel programma di valutazione a stelle del CMS.
Questo riconoscimento rappresenta la sesta volta che Alignment riceve questo onore, avendolo già ottenuto consecutivamente dal 2018 al 2022. L'azienda ha raggiunto punteggi perfetti nell'aderenza ai farmaci per diabete, ipertensione e colesterolo, oltre che nel completamento del programma di gestione della terapia farmacologica e nell'uso di statine nelle persone con diabete.
Alignment Healthcare (NASDAQ: ALHC) ha recibido el Premio a la Excelencia en Calidad Laura Cranston 2025 de PQA por su plan Medicare Advantage con cobertura de medicamentos recetados (MAPD). La compañía fue una de solo dos planes MAPD de 633 contratos elegibles en obtener este reconocimiento, representando el top 1.3%. El premio requiere una calificación mínima de 4.5 estrellas en el resumen de la Parte D y una calificación perfecta de 5 estrellas en las cinco medidas de medicamentos de PQA usadas en el programa de calificaciones por estrellas de CMS.
Este reconocimiento marca la sexta vez que Alignment recibe este honor, habiéndolo ganado previamente desde 2018 hasta 2022. La compañía logró calificaciones perfectas en adherencia a medicamentos para diabetes, hipertensión y colesterol, así como en la finalización del programa de manejo de terapia medicamentosa y el uso de estatinas en personas con diabetes.
Alignment Healthcare (NASDAQ: ALHC)는 메디케어 어드밴티지 처방약(MAPD) 플랜으로 2025년 PQA 로라 크랜스턴 품질 우수상(Laura Cranston Excellence in Quality Award)을 수상했습니다. 이 회사는 633개의 자격 있는 계약 중 단 두 개의 MAPD 플랜 중 하나로, 상위 1.3%에 해당하는 영예를 안았습니다. 이 상은 최소 4.5성급 Part D 요약 등급과 CMS 별점 프로그램에서 사용되는 다섯 가지 PQA 약물 측정 항목 모두에서 완벽한 5성 등급을 요구합니다.
이번 수상은 Alignment가 2018년부터 2022년까지 연속으로 PQA 품질 우수상을 받은 데 이어 여섯 번째입니다. 당뇨병, 고혈압, 콜레스테롤 약물 복용 순응도에서 완벽한 등급을 받았으며, 약물 치료 관리 프로그램 완료 및 당뇨병 환자의 스타틴 사용에서도 완벽한 평가를 받았습니다.
Alignment Healthcare (NASDAQ: ALHC) a reçu le Prix d'Excellence en Qualité Laura Cranston 2025 de la PQA pour son plan Medicare Advantage avec couverture des médicaments sur ordonnance (MAPD). L'entreprise a été l'un des seuls deux plans MAPD parmi 633 contrats éligibles à recevoir cette distinction, représentant le top 1,3 %. Ce prix exige une note minimale de 4,5 étoiles dans le résumé de la Partie D et une note parfaite de 5 étoiles sur les cinq mesures de médicaments PQA utilisées dans le programme d'évaluation par étoiles du CMS.
Cette reconnaissance marque la sixième fois qu'Alignment reçoit cet honneur, l'ayant déjà remporté de 2018 à 2022. L'entreprise a obtenu des notes parfaites en adhérence médicamenteuse pour le diabète, l'hypertension et le cholestérol, ainsi qu'en complétion du programme de gestion de la thérapie médicamenteuse et en utilisation de statines chez les personnes atteintes de diabète.
Alignment Healthcare (NASDAQ: ALHC) hat den PQA Laura Cranston Excellence in Quality Award 2025 für seinen Medicare Advantage-Verschreibungspflichtigen Medikamentenplan (MAPD) erhalten. Das Unternehmen war einer von nur zwei MAPD-Plänen unter 633 berechtigten Verträgen, die diese Auszeichnung erhielten, was die Top 1,3 % repräsentiert. Die Auszeichnung erfordert eine Mindestbewertung von 4,5 Sternen im Part D-Zusammenfassungsrating und eine perfekte 5-Sterne-Bewertung in allen fünf PQA-Medikamentenmaßen, die im CMS-Sternebewertungsprogramm verwendet werden.
Die Anerkennung markiert das sechste Mal, dass Alignment diese Ehre erhält, nachdem es den PQA Excellence in Quality Award bereits von 2018 bis 2022 gewonnen hatte. Das Unternehmen erreichte perfekte Bewertungen in der Medikamentenadhärenz für Diabetes, Bluthochdruck und Cholesterin sowie in der Durchführung des Medikationsmanagementprogramms und der Statin-Anwendung bei Personen mit Diabetes.
- None.
- None.
Pharmacy Quality Alliance award reaffirms Alignment’s commitment to medication adherence and pharmacy excellence for seniors
ORANGE, Calif., May 19, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) has been recognized for excellence in quality for its Medicare Advantage prescription drug (MAPD) plan by the Pharmacy Quality Alliance (PQA). The PQA has measured medication safety for the Centers for Medicare and Medicaid Services (CMS) since 2006, ensuring medication safety, adherence and appropriate use. Out of 633 eligible contracts, only
“We are incredibly honored to be one of only two MAPD plans recognized by PQA for our unwavering focus on quality and consistency in achieving medication adherence,” said Dawn Maroney, CEO, Alignment Health Plan. “This award reaffirms our mission-driven approach to combine personalized care and commitment to improving outcomes for the seniors we serve to live a healthier lifestyle.”
The 2025 PQA Laura Cranston Excellence in Quality Award goes to MAPDs with at least a 4.5-star Part D summary rating and a perfect 5-star rating on all five PQA medication measures used in CMS’s star ratings program. Alignment Health was one of two MAPDs that earned the perfect rating on the following five PQA measures: medication adherence for diabetes medications; medication adherence for hypertension (RAS antagonists); medication adherence for cholesterol (statins); medication therapy management program completion rate for comprehensive medication reviews; and statin use in persons with diabetes. CMS evaluates Medicare plan quality every year based on a 5-star rating system.
Alignment’s MAPD plans provide prescription drug coverage with personalized support to help members access the medicine they need to stay healthy, particularly those managing multiple chronic conditions.
“We are immensely proud of our team's dedication to advancing pharmacy care,” said Ruby Liu, vice president of pharmacy, Alignment Health. “Medication adherence can be a hurdle for seniors. To address that, Alignment has invested in quality through tested processes, predictive technology and personalized concierge support for our members. This commitment enhances patient health and well-being while also reducing costs for both our members and the organization.”
Alignment Health Plan received the PQA Excellence in Quality Award from 2018 to 2022 and the PQA Quality Improvement Award in 2018, becoming the first health plan to receive both PQA awards in the same year. This is the sixth time Alignment has received this honor.
The PQA has recognized Medicare prescription drug plans for their achievements in medication safety since 2011. Alignment will accept the award at the 2025 PQA Annual Meeting on May 20 in Tampa, Florida.
About Alignment Health
Alignment Health is championing a new path in senior care that empowers members to age well and live their most vibrant lives. A consumer brand name of Alignment Healthcare (NASDAQ: ALHC), Alignment Health’s mission-focused team makes high-quality, low-cost care a reality for its Medicare Advantage members every day. Based in California, the company partners with nationally recognized and trusted local providers to deliver coordinated care, powered by its customized care model, 24/7 concierge care team and purpose-built technology, AVA®. As it expands its offerings and grows its national footprint, Alignment upholds its core values of leading with a serving heart and putting the senior first. For more information, visit www.alignmenthealth.com.
Media Contact
Priya Shah
mPR, Inc. for Alignment Health
alignment@mpublicrelations.com
